Novo Nordisk files 14 lawsuits in US against companies selling duplicate drugs
Novo Nordisk files 14 lawsuits in US against companies selling duplicate drugs
Copy link
Novo Nordisk cuts its forecasts after a boom in copycats and the rise of Mounjaro
Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".
The Danish weight loss drug-maker claims "knock-off" treatments are hitting growth.
A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its…
Novo Nordisk insists its decision is unrelated to pressure from the US president
The Danish firm, which also produces Wegovy, has warned of increased pressure from "knock-off" drugs.
